Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Report from the Annual General Meeting in Nexam Chemical Holding (publ)

Today, Thursday May 17, 2018, an Annual General Meeting (the “AGM”) was held in Nexam Chemical Holding AB (publ). At the AGM, 7,943,439 shares were represented, which corresponds to approximately 12 % of the total number of shares. A summary of the resolutions adopted follows below. All resolutions were adopted with the required majority of votes.Adoption of accounts and distribution of the company’s results   The AGM resolved to adopt the presented profit and loss statement and balance sheet, as well as the consolidated profit and loss statement and consolidated balance sheet. The AGM

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release May 17, 2018, at 5:45 p.m. Nokian Tyres has received an announcement from BlackRock, Inc. on May 17, 2018, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, BlackRock, Inc.'s indirect holding in Nokian Tyres shares fell below level of 5% as well as the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below level of 5% of the share capital in Nokian Tyres plc, as result of share transactions concluded on May 16, 2018. Total positions of BlackRock, Inc. and its

Annual General Meeting in Munters Group AB

At the annual general meeting in Munters Group AB held today the following main resolutions were taken.Adoption of the income statement and the balance sheet for the company and the group The meeting resolved on the adoption of the presented income statement and the balance sheet and the consolidated income statement and consolidated balance sheet as per 31 December 2017. Dividend In accordance with the Board’s proposal, the annual general meeting resolved to declare a dividend of SEK 0.30 per share. Monday 21 May 2018 was determined as record date for the payment of dividend.

Report from Balco Group AB’s Annual General Meeting 2018

The shareholders of Balco Group AB ("Balco" or "the Company") gathered today on Thursday 17 May 2018 in Växjö, Sweden, for the Annual General Meeting.The Annual General Meeting of Balco approved the profit and loss statement and the balance sheet and the consolidated profit and loss statement and consolidated balance sheet and granted the members of the Board of Directors and the CEO discharge from liability for the financial year 2017. The Annual General Meeting resolved to allocate the Company’s profits in accordance with the proposal made by the Board of Directors in the annual report.

Appointment in Componenta’s Corporate Executive Team

Componenta Corporation Stock Exchange Release 17 May 2018 at 17.00 Mervi Immonen has been appointed Group General Counsel and as a member of the Corporate Executive Team of Componenta Corporation as of 17 May 2018. She has worked as company’s Legal Counsel since 2017 and several years in different legal and managerial positions before joining Componenta. Mervi Immonen reports to CEO and President Harri Suutari. As of 17 May 2018, Componenta’s Corporate Executive Team consist of CEO Harri Suutari, Group General Counsel Mervi Immonen, CFO Marko Karppinen and COO Pasi Mäkinen.

Amgen, Sandoz, ThermoFisher Scientific and IQVIA join Monocl’s customer portfolio

· Monocl welcomes a range of global leading pharmaceutical companies, scientific instrument manufacturers and CROs to its rapidly growing customer base. · The company closed its largest deal to date in Q1 2018 with a non-disclosed top 5 Big Pharma. · To further fuel its rapid growth, Monocl will initiate a Series A funding round during Q2 2018. Björn Carlsson, CEO of Monocl, sums it up: “The first quarter of 2018 was our strongest to date. This is very exciting since we beat our previous all-time high from the final quarter of 2017. The fact that our performance is exceeding our

Healthcare IT business Trialbee pursues strategic expansion through new talent and investment

Swedish clinical trial technology firm Trialbee announces the appointment of several new senior leadership positions and new investments. This injection of talent and funding will underpin Trialbee’s plans for corporate growth and expansion into the US market.Trialbee mobilizes and prepares for strategic expansion through the addition of new investments. Trialbee is a Swedish clinical trial technology company providing smart patient matching and engagement services to accelerate drug development for pharmaceutical companies and contract research organizations (CROs) around the world.

Summer news from Rapunzel of Sweden

Rapunzel of Sweden launches three news in limited edition for summer. A new anti-static leave-in spray that shreds and moisturises hair, a headband and a real-hair scrunchie for the ultimate "messy bun". The news is perfect for warm and lazy days at the beach, they can be styled both together or separately.Hair Scrunchie Rapunzels Hair Scrunchie in real hair gives you a trendy hairstyle in no time! With Hair Scrunchie you can quickly create a stylish look. The hair scrunchie has an genuine hair around the hairband and you can easily create a your favorite hair style and at the same

Vator Securities acted as Sole Bookrunner and Advisor in connection with Ascelia Pharmas Pre-IPO share issue

Vator Securities acted as Sole Bookrunner and Advisor in connection with the transaction raising SEK 60 million.Ascelia Pharma is a Swedish-based specialty oncology drug development company with a late stage pipeline of products with potential to significantly improve survival in cancer patients. The lead asset Mangoral® is a novel MR imaging (MRI) drug, which is being developed for detection of liver metastases in patients with severely impaired kidney function who are at risk of serious side effects if given any of the current imaging drugs on the market. Today, these patients have no

Invitation to presentation of Sectra’s year-end report on May 29

Linköping, Sweden – May 17, 2018 – The international medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will publish its year-end report for the period May 2017 to April 2018 on May 29, 2018. Sectra invites analysts, investors, and the media to attend a presentation in conjunction with the publication of the report.Publication of year-end report: 8:00 a.m. May 29, 2018 Presentation: 12:00 noon. May 29, 2018 Place: Operaterrassen in Stockholm, Sweden To attend the conference, please submit a notification via: http://www.

Voith Moves to Basware Invoice Receiving Service

Espoo, Finland, 17 May 2018 – Basware, the global leader in networked source-to-pay solutions, e-invoicing and innovative financing services, has signed a new deal with Voith Global Business Services EMEA GmbH. Voith  is a new customer to Basware. “Voith was originally looking for an OCR-based solution to digitalize their paper-based vendor invoices. But our versatile approach to start with scanning/OCR and then activate suppliers to move to electronic invoicing convinced them that Basware’s way of doing things offers better business case and is more

#18-846 Listing of instrument issued by UBS AG

As from May 21, 2018, 1 instrument issued by UBS AG will be listed on NDX Miscellaneous Investment Products Sweden. The instrument will be registered at Euroclear Sweden AB.Issuer: UBS AG Agent: Exceed For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart,

#18-845 Listing of instruments issued by SG Issuer

As from May 21, 2018, 2 instruments issued by SG Issuer will be listed on NDX Structured Products Sweden. The instrument will be registered at Euroclear Sweden AB.Issuer: SG Issuer Agent: Exceed For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the

ExpreS2ion’s core platform patent allowed in Canada

ExpreS2ion Biotech Holding AB and its affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announce that the Company’s patent application “Improved Protein Expression System”, that covers the entire ExpreS2 platform, has been allowed in Canada and will be granted with expiry June 12, 2029.“With the patent allowance in Canada, ExpreS2ion has now successfully obtained patent protection of its ExpreS2 platform in all major markets of interest. Thereby the major initial goal for our ExpreS2 platform patent portfolio, which is fundamental to our business, has been reached," says Dr. Steen

#18-844 Listing of Knock out warrants issued by Commerzbank AG

As from May 18, 2018, 19 Knock out warrants issued by Commerzbank AG will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from May 18, 2018 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: ICE Cocoa Futures ICE Coffee C Futures CBOT Wheat Future CBOT Corn Future Light Sweet Crude Oil (WTI) Futures Euro-Bund Futures - German

#18-843 Listing of Mini futures issued by Vontobel Financial Products GmbH

As from May 18, 2018, 57 Mini futures issued by Vontobel Financial Products GmbH will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Vontobel Financial Products GmbH Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from May 18, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: OMXS30 index ICE Cocoa Futures Skanska AB Investor AB ser. B Atlas Copco AB Ser. A ICE Coffee C Futures

#18-842 Listing of Knock out warrants issued by Commerzbank AG

As from May 18, 2018, 25 Knock out warrants issued by Commerzbank AG will be listed on ETP Denmark and will be included on the list for Knock-Outs. The instruments will be registered at VP SECURITIES A/S.Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from May 18, 2018 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: A.P.Moeller-Maersk A/S Coloplast A/S Danske Bank A/S DSV A/S FLSmidth & Co. A/S GN Store Nord A/S ISS Novozymes A/S Pandora AS

Arcusys Announces Corporate Name Change to Valamis

The change reflects the company's consolidated strategy and focus on their core product, Valamis - Learning Experience Platform driving the intelligent automation that is shaping the future of every company.LONDON --  May 17, 2018: Arcusys – a global leader in digital learning technologies and workforce development – announced today that it is changing its corporate name to Valamis.  "The interest of customers such as NASA Epic Challenge in our digital learning solution led us to trust that Valamis is our growth path," says CEO of Valamis, former Arcusys, Jussi

Nuevolution announces the publication of a second scientific article from the collaboration with Nobel Laureate Dr. Robert J. Lefkowitz

Stockholm, 17 May 2018. Nuevolution AB (publ) (NUE.ST) today announced the publication of the scientific article entitled "Small Molecule Positive Allosteric Modulators of the β2-Adrenergic Receptor Isolated from DNA Encoded Libraries” in the journal Molecular Pharmacology. The new article presents further exciting work from the ongoing collaboration between Nuevolution and the group of Nobel Laureate Dr. Robert J. Lefkowitz at Duke University involving the screening of Nuevolution compound libraries against an important class of targets named GPCRs. The new publication extends our

Outotec Oyj: Management transactions, Gustav Kildén

OUTOTEC OYJ STOCK EXCHANGERELEASE  MAY17, 2018  AT3:00 PMOutotec Oyj:Managementtransactions,Gustav KildénPerson subjectto thenotificationrequirementName: Kildén, GustavPosition: Other senior manager InitialNotificationReference 549300R0VN9C371W0E07_20180517113817_70number: IssuerName: Outotec OyjLEI: 549300R0VN9C371W0E07 TransactiondetailsTransaction 2018-05-16+03:00date:Nature of the Receipt of a Share-Based Incentive or Remunerationtransaction: Instrument: ShareISIN:

Outotec Oyj: Management transactions, Markku Teräsvasara

OUTOTEC OYJ STOCK EXCHANGERELEASE  MAY17, 2018  AT3:00 PMOutotec Oyj:Managementtransactions,MarkkuTeräsvasaraPerson subjectto thenotificationrequirementName: Teräsvasara, MarkkuPosition: Chief Executive Officer InitialNotificationReference 549300R0VN9C371W0E07_20180517113817_77number: IssuerName: Outotec OyjLEI: 549300R0VN9C371W0E07 TransactiondetailsTransaction 2018-05-16+03:00date:Nature of the Receipt of a Share-Based Incentive or Remunerationtransaction: Instrument:

Outotec Oyj: Management transactions, Jari Ålgars

OUTOTEC OYJ STOCK EXCHANGERELEASE  MAY17, 2018  AT3:00 PM Outotec Oyj:Managementtransactions -Jari ÅlgarsPerson subjectto thenotificationrequirementName: Ålgars, JariPosition: Chief Financial Officer InitialNotificationReference 549300R0VN9C371W0E07_20180517113817_76number: IssuerName: Outotec OyjLEI: 549300R0VN9C371W0E07 TransactiondetailsTransaction 2018-05-16+03:00date:Nature of the Receipt of a Share-Based Incentive or Remunerationtransaction: Instrument: ShareISIN:

Outotec Oyj: Management transactions, Olli Nastamo

OUTOTEC OYJ STOCK EXCHANGERELEASE  MAY17, 2018  AT3:00 PMOutotec Oyj:Managementtransactions,Olli NastamoPerson subjectto thenotificationrequirementName: Nastamo, OlliPosition: Other senior manager InitialNotificationReference 549300R0VN9C371W0E07_20180517113817_73number: IssuerName: Outotec OyjLEI: 549300R0VN9C371W0E07 TransactiondetailsTransaction 2018-05-16+03:00date:Nature of the Receipt of a Share-Based Incentive or Remunerationtransaction: Instrument: ShareISIN:

Outotec Oyj: Management transactions, Kimmo Kontola

OUTOTEC OYJ STOCK EXCHANGERELEASE  MAY17, 2018  AT3:00 PMOutotec Oyj:Managementtransactions,Kimmo KontolaPerson subjectto thenotificationrequirementName: Kontola, KimmoPosition: Other senior manager InitialNotificationReference 549300R0VN9C371W0E07_20180517113817_75number: IssuerName: Outotec OyjLEI: 549300R0VN9C371W0E07 TransactiondetailsTransaction 2018-05-16+03:00date:Nature of the Receipt of a Share-Based Incentive or Remunerationtransaction: Instrument: ShareISIN:

There are no items matching the current filter
There are no more items matching the current filter
Back to top